Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMIG4.L Regulatory News (MIG4)

  • There is currently no data for MIG4

Interim Management Statement

23 May 2023 07:00

RNS Number : 2399A
Mobeus Income & Growth 4 VCT PLC
23 May 2023
 

Mobeus Income & Growth 4 VCT plc

("the Company")

LEI: 213800IFNJ65R8AQW943

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 31 March 2023

 

Mobeus Income & Growth 4 VCT plc presents an Interim Management Statement for the quarter ended 31 March 2023. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE AND TOTAL RETURN PER SHARE

At 31 March 2023

(unaudited)

At 31 December 2022

(audited)

Net assets attributable to shareholders

£88.11 million

£83.54 million

Shares in issue

110,365,539

104,356,447

Net asset value (NAV) per share

79.83 pence

80.05 pence

Cumulative dividends paid

153.20 pence

153.20 pence

Cumulative Total return (net asset value basis) per share since inception

233.03 pence

233.25 pence

The NAV per share has decreased by 0.22 pence in the quarter (a decrease of 0.3% from the opening NAV per share).

 

OFFER FOR SUBSCRIPTION

 

On 6 February 2023, the Company allotted and issued 6,009,092 new ordinary shares, raising net funds (after costs) of £4.81 million. Following this allotment, after receiving applications for the full amount sought, the Offers for Subscription across all four Mobeus VCTs launched on 5 October 2022 were closed.

 

INVESTMENT ACTIVITY DURING THE PERIOD

 

New Investment during the period

On 7 March 2023, the Company completed a new investment of £0.25 million into Connect Earth Limited, an environmental data provider.

 

On 22 March 2023, the Company completed a new investment of £0.50 million into Cognassist Limited, an education and neuro-inclusion solutions provider.

 

Realisations during the period

In March 2023, the Company achieved a full exit of Tharstern Group Limited generating proceeds of £2.14 million. Over the life of this investment, the Company has received £3.01 million which equates to a multiple on cost of 2.6x and an IRR of 15%.

 

INVESTMENT ACTIVITY AFTER THE PERIOD END

 

New investment after the period end

On 3 May 2023, the Company completed a new investment of £0.46 million into Dayrize B.V., a sustainability impact assessment tool provider.

 

SHARE BUYBACK AFTER THE PERIOD END

 

On 18 April 2023, the Company purchased 626,264 of its own ordinary shares at a price of 76.05 pence per share.

 

All shares bought back by the Company were subsequently cancelled.

 

DIVIDEND DECLARED AFTER THE PERIOD END

 

On 13 April 2023, an interim dividend of 5.00 pence per share in respect of the year ending 31 December 2023 was declared and is payable on 26 May 2023 to all Shareholders whose names were on the register on 21 April 2023. Payment of this interim dividend will reduce NAV per share (shown above) to 74.83 pence and increase cumulative dividends paid to 158.80 pence per share.

 

Please note that all of the above information is unaudited, except that relating to 31 December 2022.

 

Other than as described above, there were no material events during the period and to the date of this announcement.

 

For further information, please contact:

Gresham House Asset Management Limited,

Company Secretary: 020 7382 0999

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCZLLFLXELLBBQ
Date   Source Headline
26th Mar 201912:33 pmRNSAnnual Financial Report
20th Mar 20194:07 pmRNSAnnual Results for the year ended 31 December 2018
20th Dec 201810:13 amRNSTransaction in Own Shares
26th Nov 20189:23 amRNSTransaction in Own Shares
16th Nov 20189:55 amRNSInterim Management Statement - 3rd Quarter Results
27th Sep 201811:11 amRNSTransaction in Own Shares
15th Aug 20185:09 pmRNSSubmission to the NSM
14th Aug 201811:37 amRNSDividend Investment Scheme - Suspension
14th Aug 201811:15 amRNSDividend Investment Scheme - Suspension
14th Aug 201810:39 amRNSHalf-year Report
20th Jun 201810:31 amRNSIssue of Equity
6th Jun 20189:33 amRNSTransaction in Own Shares
11th May 20182:34 pmRNSInterim Management Statement
11th May 20182:30 pmRNSResult of AGM
11th May 20182:26 pmRNSDividend Declaration
26th Mar 20188:50 amRNSTransaction in Own Shares
22nd Mar 20182:37 pmRNSAnnual Financial Report
20th Mar 20185:39 pmRNSAnnual Financial Report
13th Mar 20184:33 pmRNSIssue of Equity
25th Jan 201812:02 pmRNSIssue of Equity
5th Jan 201812:40 pmRNSRealisation of Investment in Gro-Group
5th Jan 201811:23 amRNSTotal Voting Rights
21st Dec 20174:33 pmRNSIssue of Equity
21st Dec 201711:49 amRNSTransaction in Own Shares
20th Dec 20171:57 pmRNSPublication of Suppl.Prospcts
30th Nov 20179:15 amRNSJoint Announcement - Fundraising Update
30th Nov 20179:15 amRNSJoint Announcement - Fundraising Update
30th Nov 20179:14 amRNSJoint Announcement - Fundraising Update
30th Nov 20179:11 amRNSJoint Announcement - Fundraising Update
22nd Nov 20179:30 amRNSIssue of Equity
21st Nov 20175:12 pmRNSDividend Declaration
21st Nov 201710:02 amRNSIssue of Equity
16th Nov 20172:01 pmRNSInterim Management Statement
10th Nov 201710:27 amRNSIssue of Equity
1st Nov 201712:44 pmRNSIncrease in Offer size. Expiry of early incentive.
20th Oct 20172:24 pmRNSDirector/PDMR Shareholding
20th Oct 20172:22 pmRNSIssue of Equity
13th Oct 20172:48 pmRNSDecision to utilise over-allotment facility
29th Sep 201710:24 amRNSDirector/PDMR Shareholding - Replacement
29th Sep 20179:18 amRNSDirector/PDMR Shareholding
29th Sep 20179:17 amRNSIssue of Equity
18th Sep 20179:09 amRNSTransaction in Own Shares
11th Sep 20174:35 pmRNSIssue of Equity
6th Sep 20174:35 pmRNSOffer for Subscription and Issue of Prospectus
6th Sep 20174:35 pmRNSOffer for Subscription and Issue of Prospectus
6th Sep 20174:34 pmRNSOffer for Subscription and Issue of Prospectus
6th Sep 20174:34 pmRNSOffer for Subscription and Issue of Prospectus
8th Aug 20175:34 pmRNSHalf-year Report
8th Aug 20173:53 pmRNSHalf-year Report
4th Aug 20175:10 pmRNSJoint Announcement - Fundraising Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.